1. Home
  2. IQV vs TPL Comparison

IQV vs TPL Comparison

Compare IQV & TPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • TPL
  • Stock Information
  • Founded
  • IQV 1982
  • TPL 1888
  • Country
  • IQV United States
  • TPL United States
  • Employees
  • IQV N/A
  • TPL N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • TPL Oil & Gas Production
  • Sector
  • IQV Health Care
  • TPL Energy
  • Exchange
  • IQV Nasdaq
  • TPL Nasdaq
  • Market Cap
  • IQV 31.6B
  • TPL 29.1B
  • IPO Year
  • IQV 2013
  • TPL N/A
  • Fundamental
  • Price
  • IQV $150.19
  • TPL $1,326.66
  • Analyst Decision
  • IQV Buy
  • TPL Strong Buy
  • Analyst Count
  • IQV 20
  • TPL 1
  • Target Price
  • IQV $236.75
  • TPL $917.00
  • AVG Volume (30 Days)
  • IQV 2.4M
  • TPL 138.6K
  • Earning Date
  • IQV 05-06-2025
  • TPL 05-07-2025
  • Dividend Yield
  • IQV N/A
  • TPL 1.16%
  • EPS Growth
  • IQV 2.74
  • TPL 12.11
  • EPS
  • IQV 7.49
  • TPL 19.72
  • Revenue
  • IQV $15,405,000,000.00
  • TPL $705,823,000.00
  • Revenue This Year
  • IQV $4.08
  • TPL $32.36
  • Revenue Next Year
  • IQV $5.88
  • TPL $16.56
  • P/E Ratio
  • IQV $20.03
  • TPL $67.74
  • Revenue Growth
  • IQV 2.81
  • TPL 11.75
  • 52 Week Low
  • IQV $135.97
  • TPL $555.71
  • 52 Week High
  • IQV $252.88
  • TPL $1,769.14
  • Technical
  • Relative Strength Index (RSI)
  • IQV 40.77
  • TPL 53.55
  • Support Level
  • IQV $137.49
  • TPL $1,220.38
  • Resistance Level
  • IQV $154.17
  • TPL $1,371.35
  • Average True Range (ATR)
  • IQV 8.48
  • TPL 78.93
  • MACD
  • IQV 1.00
  • TPL 14.83
  • Stochastic Oscillator
  • IQV 58.37
  • TPL 88.37

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About TPL Texas Pacific Land Corporation

Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. It operates its business in two reportable segments; Land and Resource Management and Water Service and Operations. The Land and Resource Management segment focuses on managing surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The Water Services and Operations segment encompasses the business of providing full-service water offerings to operators, produced-water treatment, infrastructure development, and disposal solutions. The company generates the majority of its revenue from the Land and Resource Management segment.

Share on Social Networks: